Bevespi Aerosphere
Active Ingredient(s): Glycopyrrolate + Formoterol FumarateFDA Approved: * April 25, 2016
Pharm Company: * PEARL THERAPEUTICS INC
Category: Lungs (Pulmonary)
Formoterol, also known as eformoterol, is a long-acting β2 agonist (LABA) used as a bronchodilator in the management of asthma and chronic obstructive pulmonary disease (COPD). Formoterol has an extended duration of action (up to 12h) compared to short-acting β2 agonists such as salbutamol (albuterol), which are effective for 4h to 6h. LABAs such as formoterol are used as "symptom controllers" to supplement prophylactic corticosteroid therapy. A "reliever" short-acting β2 agoni... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion
Dosage List
Bevespi Aerosphere Respiratory (Inhalation) Aerosol, Metered
NDC: 0310-4600
Labeler:
Astrazeneca Pharmaceuticals Lp
Popular Topics
Bevespi Aerosphere Reviews
I was just given this relatively new drug today called Bevespi Aerosphere. I have stage 4 emphysema. Wondering if anyone...
1 REPLY